ARCOS Transaction Reporting

Forms and Documents

Document	Type	Status	Availability
Form 333 ARCOS Transaction Reporting -- DEA Form 333	Form	Unchanged	Repair queued
1117-0003 ARCOS Supporting Statement 10-16-17.docx	Supporting Statement A	Uploaded 2017-10-16	Repair queued
21 USC 827.rtf	Supplementary Document	Uploaded 2017-08-08	Repair queued

IC Document Collections

IC ID	Collection	Type	Status	Form
12279	ARCOS Transaction Reporting -- DEA Form 333	Form	Unchanged

ICR Details

OMB Control No: 1117-0003	ICR Reference No: 202012-1117-004
Status: Received in OIRA	Previous ICR Reference No: 201708-1117-001
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: ARCOS Transaction Reporting
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 12/28/2020

	Requested	Previously Approved
Expiration Date	36 Months From Approved	01/31/2021
Responses	12,156	12,156
Time Burden (Hours)	2,342	2,342
Cost Burden (Dollars)	147,817	147,817

---

Abstract: Title 21 U.S.C. 827 requires controlled substance manufacturers and distributors to make periodic reports to the DEA regarding the sale, delivery, and other disposal of certain controlled substances. The implementing regulations are found at 21 CFR 1304.33. The Single Convention on Narcotic Drugs, 1961, and the Convention on Psychotropic Substances, 1971, impose certain reporting obligations on the United States, and aggregate data from Form 333s are provided to the International Narcotics Control Board to meet those obligations.

---

Authorizing Statute(s): US Code: 21 USC 827 Name of Law: Records and Reports of Registrants
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 44926	07/24/2020
30-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 68093	10/27/2020
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
ARCOS Transaction Reporting -- DEA Form 333	333	ARCOS

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	12,156	12,156	0	0	0	0
Annual Time Burden (Hours)	2,342	2,342	0	0	0	0
Annual Cost Burden (Dollars)	147,817	147,817	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $150,000

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 12/28/2020

---